VEGFR2 Recombinant Antibody
Applications
Reactivity
| Overview | |
| Catalog # | bsm-63075r-100uL |
| Product Name | VEGFR2 Recombinant Antibody |
| Applications |
IHC-P
IHC-F
IF(IHC-P)
|
| Reactivity | Human |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human VEGFR2 |
| Clonality | Recombinant |
| Isotype | IgG |
| Concentration | 1mg/ml |
| Purification | Purified by Protein A. |
| Storage Buffer | 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target | |
| Gene ID | 3791 |
| Swiss Prot | P35968 |
| Subcellular location | Cytoplasm, Nucleus, Secreted, Cell membrane |
| Synonyms | Vascular endothelial growth factor receptor 2; KDR; VEGF Receptor 2; CD309; CD309 antigen; Fetal liver kinase 1; FLK-1; FLK1; Kinase insert domain receptor (a type III receptor tyrosine kinase); Kinase insert domain receptor; KRD1; Ly73; Protein tyrosine kinase receptor FLK1; Protein-tyrosine kinase receptor flk-1; Tyrosine kinase growth factor receptor; VEGFR 2; VEGFR; VEGFR-2; VGFR2_HUMAN. |
| Application Dilution | |
| IHC-P | IF1:100-500 |
| IHC-F | IHC-F1:100-500 |
| IF(IHC-P) | IHC-P1:100-500 |
Frequently asked questions
Which applications is VEGFR2 Recombinant Antibody (bsm-63075R) validated for, and at what dilution?
bsm-63075R is validated for IHC-P(IF(IHC-P)) (1:100-500); IHC-F(IHC-F) (1:100-500); IF(IHC-P)(IHC-P) (1:100-500). These are recommended starting dilutions; optimal dilutions should be determined by the end user.
Which species does VEGFR2 Recombinant Antibody (bsm-63075R) react with?
Tested reactivity: Human.
How should bsm-63075R be stored?
Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. Storage buffer: 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
What immunogen was used to raise VEGFR2 Recombinant Antibody (bsm-63075R)?
KLH conjugated synthetic peptide derived from human VEGFR2